期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺栓塞合并溃疡性结肠炎3例临床分析

下载PDF
导出
摘要 肺血栓栓塞症（PTE）是各种内源性或外源性栓子阻塞肺动脉或其分支引起的肺循环障碍的临床综合征[1]，其常见的危险因素包括：长期卧床、外科手术、恶性肿瘤、克罗恩病、妊娠等，而近期研究表明溃疡性结肠炎（UC）发生静脉血栓栓塞病（VTE）的危险性是普通人群的2倍，是肺血栓栓塞症独立的危险因素[2]，本文回顾性分析3例肺栓塞合并UC患者的临床资料。报道如下。
作者 王兰 江莲 赵洪达 唐良法
机构地区 江苏省江阴市人民医院呼吸内科
出处 《浙江临床医学》 2015年第11期1976-1977,共2页 Zhejiang Clinical Medical Journal
关键词 溃疡性结肠炎 肺栓塞 临床分析 肺血栓栓塞症 危险因素 临床综合征 肺循环障碍 血栓栓塞病
分类号 R259.746.2 [医药卫生—中西医结合]
  • 相关文献

参考文献11

  • 1Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 1999,353:1386-1389.
  • 2Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism. Gut, 2004,53 (4) :542-548.
  • 3Koutroubakis IE. Therapy insight: Vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol, 2005,2(6):266-272.
  • 4Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role ofplatelets. Gut, 1993,34(2):247-251.
  • 5Jain S, Bhatt P, Muralikrishna GK, et al. Extensive arterial and venous thrombosis in a patient with ulcerative colitisa case report. MedGenMed, 2005,7(2):10.
  • 6戎兰,蒋晓芸,乔健,蒋义斌,钟良.炎症性肠病患者血小板活化和血小板聚集力的变化[J].中华消化杂志,2009,29(4):264-266. 被引量：9
  • 7Koutroubakis IE, Theodoropoulou A, Xidakis C, et al. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol, 2004, 16:1147-11452.
  • 8Danese S, de La Motte C, Sturm A, et al. Platelets trigger a CD40- dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology, 2003,124:1249-1264.
  • 9Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut, 2003,52:1435-1441.
  • 10Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in phsma of patients with inflammatory bowel disease. Dig Dis Sci, 1995,40:1883-1889.

二级参考文献16

  • 1Bernstin CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost, 2001,85 : 430-434.
  • 2Quera R, Shanahan F. Thromboembotism-an important manifestation of inflammatory bowel disease. Am J Gastroenterol, 2004,99 : 1971-1973.
  • 3Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and frbrinolysis. Pathophysiol Haemost Thromb, 2003 2004, 33:375-381.
  • 4Sutherland LR, Mattin F, Greer S, et al. 5-Aminosalicyclic acid enema in the treatment of distal ulcerative colitis, proctrosigmoditis, and proctitis. Gastroenterology, 1987, 92:1894-1898.
  • 5Harvey RF, Bradshaw JM. A simple index of Crohn' s- disease activity. Lancet, 1980,1 : 514.
  • 6Andoh A, Yoshida T, Yagi Y, et al. Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol,2006,41:47-54.
  • 7Morowitz DA, Allen LW, Kirsner JB. Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med, 1968: 68:1013-1021.
  • 8Danese S, Kattz JA, Saibeni S, et at. Activated platelats are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease. Gut, 2003, 52: 1435-1441.
  • 9Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol, 1997,9 : 1213-1217.
  • 10欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量：751

共引文献19

浙江临床医学
2015年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部